Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a single-source cooperative agreement to Northwestern University for the continuation of the Liver Cirrhosis Network's Scientific and Data Coordination Center (SDCC). This funding opportunity aims to support the completion of enrollment in the Liver Cirrhosis Network Cohort Study and the Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU) clinical trial, emphasizing substantial NIH involvement in research design, data management, and coordination of clinical centers. The total funding amount is $1,850,000, with applications due by February 9, 2026, and an anticipated project start date in December 2026. For further inquiries, interested parties can contact the NIDDK at NIDDK_DDN@nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information within the NOFO for additional information on eligibility.Eligible OrganizationsOnly the following applicant is eligible to apply for this single source funding: Northwestern University. Please refer to Section I. Notice of Funding Opportunity Information for more details.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.